Novartis, producers of innovative healthcare solutions, has announced the launch of its elevateMS study. The study aims to utilize a mobile application for people with multiple sclerosis (MS) to collect sensor-based data to improve research.

The study incorporates a mobile app that allows participants to complete questionnaires, capture passive and active movement data, and complete functional tasks. Data are stored on the app where participants are able to view changes over time and inform researchers about living with MS.

"As physicians, we always want to know how our patients with MS are doing on the treatments we prescribe," said Stanley Cohan, MD, PhD, medical director of Providence Multiple Sclerosis Center in Portland, Oregon. "With the elevateMS app, study participants can frequently document their symptoms in a personal health story. In turn, this data may provide researchers with new ways to look at disease progression and treatment effectiveness.”